A Preview Of Amylyx Pharma's Earnings
Portfolio Pulse from Benzinga Insights
Amylyx Pharma (NASDAQ:AMLX) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $0.10. The company's past performance shows a mix of EPS estimates and actuals, with the stock price generally decreasing. Over the last 52-week period, shares are down 15.19%.
August 09, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amylyx Pharma is expected to report an EPS of $0.10 in its upcoming earnings report. The company's stock has been on a downward trend, with shares down 15.19% over the last 52 weeks.
The company's stock has been on a downward trend, which could continue if the earnings report does not meet or exceed expectations. The estimated EPS of $0.10 is a key figure that investors will be watching.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100